Results

Total Results: 1,217 records

Showing results for "description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
    January 01, 2009 - Applicability Summary Table Template Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association Comparison Strength of Evidence Conclusions With Description
  2. effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
    May 01, 2011 - Data Analysis Evidence tables and qualitative description of results were presented for all included … Results Description of Included Studies The search strategy identified 9,357 citations; 83 unique … The most common sources of potential bias were inadequate description of the randomization procedure
  3. effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
    January 01, 2011 - Elements to be included in a summary table characterizing the applicability of a body of studies Domain Description … Example summary table characterizing the applicability of a body of studies Domain Description of applicability … Example summary table for body of evidence Comparison Strength of Evidence Conclusions with description
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
    March 29, 2011 - participant characteristics (age, diagnosis, symptom severity, etc.), intervention characteristics (description … author, year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  5. S29 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
    October 01, 2007 - Vignettes were used to provide all interviewees with a common point of refer- ence13,14 and a “listenable” description … intended to provide quantitative data; rather, they were intended to provide a thorough and accurate description … Potential Barriers Major Themes Description Impact on satisfaction Members, physicians, formulary committee
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - Applicability Summary Table Template Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association Comparison Strength of Evidence Conclusions With Description
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
    January 01, 2011 - Elements to be included in a summary table characterizing the applicability of a body of studies Domain Description … Example summary table characterizing the applicability of a body of studies Domain Description of applicability … Example summary table for body of evidence Comparison Strength of Evidence Conclusions with description
  8. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - author, year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - author, year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
    May 24, 2010 - held concepts of high quality including the following: a formal randomized controlled study; clear description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
    April 06, 2010 - criteria: (1) appropriateness of the randomization scheme, (2) appropriateness of the blinding, and (3) description … concepts of high quality, including the following: a formal randomized controlled design; a clear description
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
    June 01, 2010 - contain some common elements (e.g., author, publication year, study location, time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  13. effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
    January 01, 2011 - The supplement concludes with a description of how Directed Acyclic Graphs (DAGs) can be used to select … The supplement concludes with a description of how Directed Acyclic Graphs (DAGs) can be used to select
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
    January 27, 2014 - Peer Reviewer#1 Introduction The description needs to be clarified regarding the clinical indications … Peer Reviewer#1 Methods There is no description of whether or not the authors included grey literature … Peer Reviewer#1 Methods Within the description of the data synthesis methods the authors need to justify … An explanation of how pain was evaluated is included in each study description.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-surgery-preparation_research-protocol.pdf
    March 26, 2013 - Please see the preceding section for a detailed description of the populations, interventions, and outcomes … features: lowest likelihood of confounding due to comparison to a randomized controlled group; a clear description … In the event of protocol amendments, the date of each amendment will be accompanied by a description
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
    October 05, 2012 - However, when we read a submitted version of this paper we found their description of the intervention
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
    March 07, 2012 - None of the studies looked specifically at children with joint swelling; we added this to the description … operating characteristic curve for different tests and diagnoses could be improved with a detailed figure description … We have reworded the outcome description for KQ5.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: